Aliases & Classifications for Herpes Zoster

MalaCards integrated aliases for Herpes Zoster:

Name: Herpes Zoster 12 72 24 50 51 3 41 14
Shingles 12 72 24 50 40 3 59
Zoster 24 3
Herpes Zoster Disease 69
Herpes Zona 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8536
ICD9CM 34 053
MeSH 41 D006562
NCIt 46 C71079
UMLS 69 C0019360

Summaries for Herpes Zoster

MedlinePlus : 40 Shingles is a disease caused by the varicella-zoster virus - the same virus that causes chickenpox. After you have chickenpox, the virus stays in your body. It may not cause problems for many years. As you get older, the virus may reappear as shingles. Although it is most common in people over age 50, anyone who has had chickenpox is at risk. You can't catch shingles from someone who has it. However, if you have a shingles rash, you can pass the virus to someone who has never had chickenpox. This would usually be a child, who could get chickenpox instead of shingles. The virus spreads through direct contact with the rash, and cannot spread through the air. Early signs of shingles include burning or shooting pain and tingling or itching, usually on one side of the body or face. The pain can be mild to severe. Rashes or blisters appear anywhere from one to 14 days later. If shingles appears on your face, it may affect your vision or hearing. The pain of shingles may last for weeks, months, or even years after the blisters have healed. There is no cure for shingles. Early treatment with medicines that fight the virus may help. These medicines may also help prevent lingering pain. A vaccine may prevent shingles or lessen its effects. The vaccine is recommended for people 60 or over. In some cases doctors may give it to people ages 50 to 59. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Herpes Zoster, also known as shingles, is related to uveitis and folliculitis, and has symptoms including rash which is followed by blisters, headache and fever. An important gene associated with Herpes Zoster is DPYD (Dihydropyrimidine Dehydrogenase), and among its related pathways/superpathways are Allograft rejection and Influenza A. The drugs Capsaicin and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include nerve fiber, skin and t cells.

Disease Ontology : 12 A viral infectious disease that results_in infection located in nerve fiber, has material basis in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted_by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has symptom rash which is followed by blisters, has symptom headache, has symptom fever, has symptom malaise, has symptom itching, has symptom burning pain, and has symptom paresthesia.

Genetics Home Reference : 24 Shingles (also known as herpes zoster) results from infection by the varicella zoster virus. This common virus causes chickenpox (also known as varicella), which is characterized by itchy spots on the skin that cover the whole body and usually occurs in childhood or adolescence. After the body fights the initial infection, the varicella zoster virus remains in nerve cells for the rest of a person's life. Because the virus is controlled by immune system cells called T cells, it is generally inactive (latent) and typically causes no health problems. However, in some people, the virus becomes active again (reactivates) and causes shingles. Shingles can occur at any age, although it is rare in childhood and becomes more common after age 50.

CDC : 3 Almost 1 out of every 3 people in the United States will develop shingles, also known as zoster or herpes zoster, in their lifetime. There are an estimated 1 million cases of shingles each year in this country. Anyone who has recovered from chickenpox may develop shingles; even children can get shingles. However, the risk of shingles increases as you get older.

NINDS : 50 Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain (which can be severe), or sometimes numbness or itch,generally on one side of the body. After several days or a week, a rash of fluid-filled blisters, similar to chickenpox, appears in one area on one side of the body. Shingles pain can be mild or intense.  Some people have mostly itching; some feel pain from the gentlest touch or breeze.  The most common location for shingles is a band, called a dermatome, spanning one side of the trunk around the waistline. Anyone who has had chickenpox is at risk for shingles.  Scientists think that some of the virus particles from the original exposure to the varicella-zoster virus,leave the skin blisters and move into the nervous system.  When the varicella-zoster virus reactivates, the virus moves back down the long nerve fibers that extend from the sensory cell bodies to the skin.  The viruses multiply, the tell-tale rash erupts, and the person now has shingles.

PubMed Health : 59
About shingles: Anyone who has already had chickenpox is at risk of developing shingles later on. Both are caused by the same virus, the varicella-zoster virus. This virus stays dormant (inactive) in the body after a chickenpox infection. But it can become active again years later and cause shingles (herpes zoster): a rash with blisters that usually forms a band across the skin and is often very painful. The rash normally only affects one side of the body.People who have been vaccinated against chickenpox can still get shingles. But this is thought to be less common than developing it after having chickenpox.Shingles is particularly common in older people. Although it can be very unpleasant, it’s usually over in about two to four weeks if there are no complications.Shingles is contagious, but only for people who have never had chickenpox. In that case the infection only causes chickenpox, and not shingles.

Wikipedia : 72 Shingles, also known as herpes zoster, is a viral disease characterized by a painful skin rash with... more...

Related Diseases for Herpes Zoster

Diseases related to Herpes Zoster via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 358)
# Related Disease Score Top Affiliating Genes
1 uveitis 30.5 IFNA2 IFNG IL10
2 folliculitis 30.4 FCGR3A IFNG
3 discoid lupus erythematosus 30.3 IFNA2 IL10
4 orbital plasma cell granuloma 30.1 FCGR3A IFNA2
5 lepromatous leprosy 29.7 IFNG IL10 IL2
6 leprosy 3 29.7 IFNG IL10 IL2
7 toxic shock syndrome 29.7 IFNG IL10 IL2
8 tetanus 29.7 IFNG IL10 IL2
9 pulmonary tuberculosis 29.7 IFNG IL10 IL2
10 aseptic meningitis 29.7 IFNG IL10
11 alopecia areata 29.5 HLA-A IFNG IL2
12 hematopoietic stem cell transplantation 29.5 HLA-A IFNG IL10 IL2
13 spondyloarthropathy 29.2 HLA-A IFNG IL10 IL2
14 graft-versus-host disease 29.2 HLA-A IFNG IL10 IL2
15 hepatitis c 29.2 IFNA2 IFNG IL10
16 acquired immunodeficiency syndrome 29.1 FCGR3A IFNA2 IFNG IL10 IL2
17 autoimmune disease 29.0 COL17A1 FCGR3A IFNG IL10 IL2
18 geniculate herpes zoster 12.7
19 herpes zoster ophthalmicus 12.6
20 postherpetic neuralgia 11.7
21 myoclonus and ataxia 11.7
22 episodic pain syndrome, familial, 1 10.5
23 hyperlucent lung 10.5 IFNG IL10
24 sporotrichosis 10.4 IFNG IL10
25 baylisascariasis 10.4 IFNG IL10
26 autoimmune encephalitis 10.4 IFNG TRPV1
27 chronic graft versus host disease 10.4 IFNG IL10
28 pericardial tuberculosis 10.4 IFNG IL10
29 recurrent respiratory papillomatosis 10.4 IFNA2 IL2
30 tuberculoid leprosy 10.4 IFNG IL10
31 orofacial granulomatosis 10.4 IFNG IL10
32 buruli ulcer 10.4 IFNG IL10
33 variola major 10.4 IFNG IL2
34 autoimmune myocarditis 10.4 IFNG IL2
35 berylliosis 10.4 IFNG IL2
36 aging 10.3
37 atopic keratoconjunctivitis 10.3 IFNG IL2
38 retinitis pigmentosa 44 10.3 IL10 IL2
39 fascioliasis 10.3 IFNG IL10
40 chronic orbital inflammation 10.3 FCGR3A IFNA2
41 multicentric castleman disease 10.3 IFNG IL10
42 burning mouth syndrome 10.3 IL2 TRPV1
43 primary systemic mycosis 10.3 IFNG IL10
44 crohn's colitis 10.3 IFNG IL2
45 microscopic colitis 10.3 IFNG IL2
46 hand, foot and mouth disease 10.3 IFNG IL10
47 neutropenia 10.3 DPYD FCGR3A IFNA2
48 arthritis 10.3
49 poliomyelitis 10.2 FCGR3A IFNG IL10
50 posterior uveitis 10.2 IFNG IL2

Graphical network of the top 20 diseases related to Herpes Zoster:



Diseases related to Herpes Zoster

Symptoms & Phenotypes for Herpes Zoster

Symptoms:

12
  • rash which is followed by blisters
  • headache
  • fever
  • malaise
  • itching
  • burning pain
  • paresthesia

UMLS symptoms related to Herpes Zoster:


sleeplessness, equilibration disorder, vertigo/dizziness, chronic pain, tremor, syncope, seizures, sciatica, pruritus, pain, headache, fever, exanthema, back pain, angina pectoris

Drugs & Therapeutics for Herpes Zoster

PubMedHealth treatment related to Herpes Zoster: 59

Pain and fever can be relieved with medication such as acetaminophen (paracetamol) or acetylsalicylic acid (the drug in medicines like Aspirin). Prescription painkillers are sometimes used to relieve more severe pain.Thorough skin care is recommended if you have shingles. Antiseptic or anti-itch lotions, gels and powders are often used to relieve the itching and dry out the blisters. Most of them contain tanins, zinc, menthol or polidocanol. If blisters have already formed, people are sometimes advised to use cooling wraps. But there’s no good scientific research on how well these treatments work.Drugs that fight viruses can be used in people who are over 50 or have a weakened immune system, if the condition is very severe, affects the head and neck area, or there is a higher risk of complications. This is known as "antiviral therapy." Using antiviral medication early on can help speed up recovery and make the pain go away faster. So people are advised to start antiviral therapy no later than 72 hours after the rash starts. In severe cases the medicine can also be given through a drip into a vein (intravenous infusion). If the ear is affected, steroids are often used too. But it still isn’t clear what pros and cons this kind of combination therapy may have.

Drugs for Herpes Zoster (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 371)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Capsaicin Approved Phase 4,Phase 3,Phase 2 404-86-4 1548943
2
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
3
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
4
Foscarnet Approved Phase 4 4428-95-9, 63585-09-1 3415
5
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
6
Nepafenac Approved, Investigational Phase 4 78281-72-8 151075
7
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
8
Ethanol Approved Phase 4 64-17-5 702
9
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2 60142-96-3 3446
10
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
11
Adalimumab Approved Phase 4 331731-18-1 16219006
12
Budesonide Approved Phase 4 51333-22-3 5281004 63006
13
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2 148553-50-8 5486971
14
gamma-Aminobutyric acid Approved, Investigational Phase 4,Phase 3 56-12-2 119
15
Tofacitinib Approved, Investigational Phase 4,Phase 2 477600-75-2
16
St. John's Wort Approved, Investigational, Nutraceutical Phase 4 84082-80-4
17
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2 58-05-9 143 6006
18
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 59-30-3 6037
19
Phosphonoacetic Acid Experimental Phase 4 4408-78-0 546
20 Acyclovir Phase 4,Phase 3,Phase 2,Phase 1
21 valacyclovir Phase 4,Phase 3,Phase 2,Phase 1
22 Prednisolone acetate Phase 4,Phase 3,Phase 2
23 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
24 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
25 Methylprednisolone acetate Phase 4,Phase 3,Phase 2
26 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2
27 Reverse Transcriptase Inhibitors Phase 4,Phase 3
28 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1
29 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Neuroprotective Agents Phase 4,Phase 3,Phase 2
31 Neurotransmitter Agents Phase 4,Phase 3,Phase 2
32 Cyclooxygenase 2 Inhibitors Phase 4
33 Cyclooxygenase Inhibitors Phase 4,Phase 3,Phase 1
34 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Phase 1
35 Vaccines Phase 4,Phase 2,Phase 3,Phase 1
36 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
37 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
38 Dermatologic Agents Phase 4,Phase 3,Phase 2
39 Hormones Phase 4,Phase 3,Phase 2,Phase 1
40 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
41 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
42 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1
43 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
44 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2
45 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
46 Prednisolone phosphate Phase 4,Phase 3,Phase 2
47 Antimetabolites Phase 4,Phase 3,Phase 2
48 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1
49 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2
50 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 461)

# Name Status NCT ID Phase Drugs
1 Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster Unknown status NCT02151240 Phase 4 Foscarnet Sodium;Acyclovir
2 Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine Unknown status NCT02146469 Phase 4
3 The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination Unknown status NCT01866566 Phase 4
4 Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Unknown status NCT00940940 Phase 4
5 Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies Unknown status NCT00865540 Phase 4 prednisolone acetate 1%;ketorolac tromethamine 0.4%;nepafenac 0.1%;methylcellulose 0.5%
6 Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain Unknown status NCT01264237 Phase 4 Etoricoxib;Placebo
7 Qutenza for Critical Ischaemia in End Stage Renal Failure Unknown status NCT01704339 Phase 4 QUTENZA
8 Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care Unknown status NCT01595347 Phase 4 Hyper-oxigenated fatty acid
9 T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020 Completed NCT01911065 Phase 4
10 Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT02173899 Phase 4
11 Safety of a Second Dose of Biken's Varicella Vaccine Completed NCT00830648 Phase 4
12 A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Completed NCT02152800 Phase 4 valacyclovir hydrocholoride
13 ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034) Completed NCT01556451 Phase 4
14 Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin Completed NCT01684072 Phase 4
15 Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT01817270 Phase 4
16 Zostavax® at Minimum Release Specification Approaching Expiry (V211-044) Completed NCT00681031 Phase 4
17 Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine Completed NCT01815073 Phase 4
18 The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children Completed NCT01138215 Phase 4
19 Varicella Vaccination With Pulmicort Completed NCT00641446 Phase 4 budesonide;varicella zoster virus
20 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ Completed NCT02958345 Phase 4
21 ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020) Completed NCT00550745 Phase 4
22 Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis Completed NCT01356004 Phase 4 live attenuated chicken pox vaccine;saline, efficacy
23 MMR and Varicella Vaccine in Premature Infants Completed NCT00156559 Phase 4
24 Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) Completed NCT00312858 Phase 4
25 Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00126997 Phase 4
26 Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) Completed NCT00326183 Phase 4
27 Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza Completed NCT01693380 Phase 4
28 Palatability Testing of a New Paediatric Formulation of Valacyclovir Completed NCT01682109 Phase 4 Valacyclovir
29 Safety Study of a Refrigerator-stable Formulation of VARIVAX® Completed NCT00432731 Phase 4
30 An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate Completed NCT02187055 Phase 4 Tofacitinib with methotrexate;Tofacitinib without methotrexate
31 MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine Completed NCT02225327 Phase 4
32 Pregabalin in the Treatment of Essential Tremor Completed NCT00646451 Phase 4 pregabalin;placebo capsules
33 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
34 Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV Completed NCT00329251 Phase 4
35 Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) Completed NCT00760747 Phase 4 Atomoxetine
36 Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients Recruiting NCT03016884 Phase 4
37 Zoster Eye Disease Study Recruiting NCT03134196 Phase 4 Masked Placebo;Masked Oral Valacyclovir
38 Immune Response to Shingles Vaccination Recruiting NCT02624375 Phase 4 Zoster Vaccine Live
39 Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine Recruiting NCT03330171 Phase 4
40 Acupuncture in Herpes Zoster Neuralgia (ACUZoster) Recruiting NCT00885586 Phase 4 gabapentine
41 Safety and Immunogenicity of a Zoster Vaccine in SLE Recruiting NCT02477150 Phase 4
42 "Equistasi" and Gait in Hemiparesis Recruiting NCT02714478 Phase 4
43 Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine Active, not recruiting NCT02514018 Phase 4
44 Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children Active, not recruiting NCT01982409 Phase 4
45 The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination Enrolling by invitation NCT01830283 Phase 4
46 Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against Chickenpox Enrolling by invitation NCT02383797 Phase 4
47 Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine Not yet recruiting NCT02026089 Phase 4
48 ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors Not yet recruiting NCT02444936 Phase 4 ZOSTAVAX
49 Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination Not yet recruiting NCT03350698 Phase 4
50 Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy Terminated NCT02408159 Phase 4 Varicella Zoster Vaccine;Placebo

Search NIH Clinical Center for Herpes Zoster

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: herpes zoster

Genetic Tests for Herpes Zoster

Anatomical Context for Herpes Zoster

The Foundational Model of Anatomy Ontology organs/tissues related to Herpes Zoster:

18
Nerve Fiber

MalaCards organs/tissues related to Herpes Zoster:

38
Skin, T Cells, Eye, Testes, Brain, Bone, Kidney

Publications for Herpes Zoster

Articles related to Herpes Zoster:

(show top 50) (show all 1301)
# Title Authors Year
1
Wolf's isotopic nonresponse in healed herpes zoster in erythroderma. ( 29393080 )
2018
2
Paraspinal muscle involvement in herpes zoster-induced abdominal wall pseudohernia revealed by electrophysiological and radiological studies. ( 29406921 )
2018
3
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine. ( 29409017 )
2018
4
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines. ( 29370152 )
2018
5
Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway. ( 29366704 )
2018
6
Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study. ( 29391771 )
2018
7
Herpes zoster infection after topical steroid use in the setting of tumid lupus erythematosus. ( 29379863 )
2018
8
Unusual case of hemidiaphragmatic paralysis secondary to cervical herpes zoster. ( 29367364 )
2018
9
Herpes zoster at the vaccination site in immunized healthy children. ( 29405375 )
2018
10
Use and impact of herpes zoster prophylaxis in myeloma patients treated with proteasome inhibitors. ( 29390929 )
2018
11
Associations of Perceived Mental Stress, Sense of Purpose in Life, and Negative Life Events With the Risk of Incident Herpes Zoster and Postherpetic Neuralgia: The SHEZ Study. ( 29036443 )
2018
12
Active Herpes Zoster Infection Involving Lumbosacral Dermatome, an Unusual Site of Manifestation and Incidental Finding in Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan. ( 29398967 )
2018
13
Herpes zoster chronification to postherpetic neuralgia induces brain activity and grey matter volume change. ( 29423004 )
2018
14
Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged a8Y50 years: A prospective study. ( 29428228 )
2018
15
Effectiveness of continuous epidural analgesia on acute herpes zoster and postherpetic neuralgia: A retrospective study. ( 29384888 )
2018
16
Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis. ( 29231748 )
2018
17
Age-dependent trigeminal and female-specific lumbosacral increase in herpes zoster distribution in the elderly. ( 29395575 )
2018
18
Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation. ( 29426830 )
2018
19
Safety, and Humoral and Cell-mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis. ( 29419465 )
2018
20
Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. ( 29431387 )
2017
21
Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors. ( 28874322 )
2017
22
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. ( 28057661 )
2017
23
Herpes zoster ophthalmicus and strabismus: a unique cause of secondary Brown syndrome. ( 28625469 )
2017
24
Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster. ( 29451274 )
2017
25
Rare case of herpes zoster ophthalmicus with orbital myositis, oculomotor nerve palsy and anterior uveitis. ( 28195080 )
2017
26
Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study. ( 28940695 )
2017
27
Mycosis fungoides occurring at the site of previous herpes zoster eruption. ( 29280139 )
2017
28
A 48-Year-Old Male with Cutaneous Metastases of NUT Midline Carcinoma Misdiagnosed as Herpes Zoster. ( 29279703 )
2017
29
Localized hypohidrosis is an unrecognized sequela of herpes zoster. ( 27986141 )
2017
30
Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant. ( 28945107 )
2017
31
Local Brain Activity Differences Between Herpes Zoster and Postherpetic Neuralgia Patients: A Resting-State Functional MRI Study. ( 28727713 )
2017
32
Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis. ( 28895088 )
2017
33
Risk Factors for Aseptic Meningitis in Herpes Zoster Patients. ( 28566903 )
2017
34
Effect of Zhuang medicine medicated thread moxibustion on protomics in serum of postherpetic neuralgia patient with Herpes zoster. ( 28671082 )
2017
35
Herpes zoster ophthalmicus in a 1-year-old child. ( 29054900 )
2017
36
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. ( 28086817 )
2017
37
Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults a8Y50A years of age with a prior history of herpes zoster: a phase III, non-randomized, open-label clinical trial. ( 28068212 )
2017
38
Complex Regional Pain Syndrome following an Episode of Herpes Zoster: A Case Report. ( 28819596 )
2017
39
Orbital cellulitis due to ophthalmic herpes zoster in an immunocompetent child: A case report. ( 28802683 )
2017
40
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy. ( 28845604 )
2017
41
Identification of herpes zoster associated temporal arteritis among cases of giant cell arteritis. ( 29294312 )
2017
42
Posterior Scleritis with Choroidal Effusion Secondary to Herpes Zoster Ophthalmicus. ( 28981391 )
2017
43
Shoulder pain due to cervical radiculopathy: an underestimated long-term complication of herpes zoster virus reactivation? ( 28798978 )
2017
44
Pediatric vaccine-strain herpes zoster: a case series. ( 28944968 )
2017
45
Rapid development of cutaneous melanoma metastases after herpes zoster infection in a radiotherapy field. ( 28940227 )
2017
46
Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ Study. ( 28091339 )
2017
47
Rheumatoid arthritis: Reducing the risk of herpes zoster. ( 28905860 )
2017
48
Herpes Zoster Ophthalmicus with Orbital Apex Syndrome-Difference in Outcomes and Literature Review. ( 28622058 )
2017
49
Rapid diagnosis of herpes zoster by loop-mediated isothermal amplification in a pregnant woman showing folliculitis-like eruption without vesicles. ( 28488349 )
2017
50
Effect of Single Intra-cutaneous Injection for Acute Thoracic Herpes Zoster and Incidence of Postherpetic Neuralgia. ( 29153295 )
2017

Variations for Herpes Zoster

Expression for Herpes Zoster

Search GEO for disease gene expression data for Herpes Zoster.

Pathways for Herpes Zoster

Pathways related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 21)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.67 HLA-A IFNA2 IFNG IL10 IL2
2
Show member pathways
12.58 HLA-A IFNA2 IFNG IL2
3
Show member pathways
12.35 IFNA2 IFNG IL10 IL2
4
Show member pathways
12.18 IFNA2 IFNG IL10 IL2
5
Show member pathways
12.13 FCGR3A HLA-A IFNA2 IFNG IL2
6
Show member pathways
12.05 FCGR3A IFNG IL10
7 12.03 FCGR3A IFNA2 IFNG IL10
8
Show member pathways
11.81 HLA-A IFNG IL2
9
Show member pathways
11.76 IFNG IL10 IL2
10 11.69 IFNA2 IFNG IL10 IL2
11 11.63 IFNG IL10 IL2
12 11.61 IFNA2 IFNG IL10 IL2
13
Show member pathways
11.49 HLA-A IFNG IL2
14 11.38 GYPC IFNG IL10
15 11.3 IFNG IL10 IL2
16
Show member pathways
11.23 HLA-A IFNA2 IFNG IL10 IL2
17
Show member pathways
11.17 IFNG IL10 IL2
18 11.13 IFNA2 IFNG IL10 IL2
19 11.03 IFNG IL2
20 11.02 IFNG IL10 IL2
21 10.75 IFNG IL10 IL2

GO Terms for Herpes Zoster

Biological processes related to Herpes Zoster according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of receptor activity GO:0010469 9.62 IFNA2 IFNG IL10 IL2
2 positive regulation of peptidyl-serine phosphorylation of STAT protein GO:0033141 9.26 IFNA2 IFNG
3 regulation of regulatory T cell differentiation GO:0045589 9.16 IFNG IL2
4 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.13 IFNA2 IFNG IL2
5 immune response GO:0006955 9.02 FCGR3A HLA-A IFNG IL10 IL2

Molecular functions related to Herpes Zoster according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 8.92 IFNA2 IFNG IL10 IL2

Sources for Herpes Zoster

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....